Adjuvant Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adjuvant Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Chemotherapy Radiotherapy Hormonotherapy Others Segment by Application Hospital Medical Institution Others By Company Merck Bayer Johnson & Johnson AstraZenca Mylan AbbVie Novartis By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Adjuvant Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy 1.2.3 Radiotherapy 1.2.4 Hormonotherapy 1.2.5 Others 1.3 Market by Application 1.3.1 Global Adjuvant Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Medical Institution 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Adjuvant Therapy Market Perspective (2017-2028) 2.2 Adjuvant Therapy Growth Trends by Region 2.2.1 Adjuvant Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Adjuvant Therapy Historic Market Size by Region (2017-2022) 2.2.3 Adjuvant Therapy Forecasted Market Size by Region (2023-2028) 2.3 Adjuvant Therapy Market Dynamics 2.3.1 Adjuvant Therapy Industry Trends 2.3.2 Adjuvant Therapy Market Drivers 2.3.3 Adjuvant Therapy Market Challenges 2.3.4 Adjuvant Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Adjuvant Therapy Players by Revenue 3.1.1 Global Top Adjuvant Therapy Players by Revenue (2017-2022) 3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Adjuvant Therapy Revenue 3.4 Global Adjuvant Therapy Market Concentration Ratio 3.4.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2021 3.5 Adjuvant Therapy Key Players Head office and Area Served 3.6 Key Players Adjuvant Therapy Product Solution and Service 3.7 Date of Enter into Adjuvant Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Adjuvant Therapy Breakdown Data by Type 4.1 Global Adjuvant Therapy Historic Market Size by Type (2017-2022) 4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2023-2028) 5 Adjuvant Therapy Breakdown Data by Application 5.1 Global Adjuvant Therapy Historic Market Size by Application (2017-2022) 5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Adjuvant Therapy Market Size (2017-2028) 6.2 North America Adjuvant Therapy Market Size by Type 6.2.1 North America Adjuvant Therapy Market Size by Type (2017-2022) 6.2.2 North America Adjuvant Therapy Market Size by Type (2023-2028) 6.2.3 North America Adjuvant Therapy Market Share by Type (2017-2028) 6.3 North America Adjuvant Therapy Market Size by Application 6.3.1 North America Adjuvant Therapy Market Size by Application (2017-2022) 6.3.2 North America Adjuvant Therapy Market Size by Application (2023-2028) 6.3.3 North America Adjuvant Therapy Market Share by Application (2017-2028) 6.4 North America Adjuvant Therapy Market Size by Country 6.4.1 North America Adjuvant Therapy Market Size by Country (2017-2022) 6.4.2 North America Adjuvant Therapy Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Adjuvant Therapy Market Size (2017-2028) 7.2 Europe Adjuvant Therapy Market Size by Type 7.2.1 Europe Adjuvant Therapy Market Size by Type (2017-2022) 7.2.2 Europe Adjuvant Therapy Market Size by Type (2023-2028) 7.2.3 Europe Adjuvant Therapy Market Share by Type (2017-2028) 7.3 Europe Adjuvant Therapy Market Size by Application 7.3.1 Europe Adjuvant Therapy Market Size by Application (2017-2022) 7.3.2 Europe Adjuvant Therapy Market Size by Application (2023-2028) 7.3.3 Europe Adjuvant Therapy Market Share by Application (2017-2028) 7.4 Europe Adjuvant Therapy Market Size by Country 7.4.1 Europe Adjuvant Therapy Market Size by Country (2017-2022) 7.4.2 Europe Adjuvant Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Adjuvant Therapy Market Size (2017-2028) 8.2 Asia-Pacific Adjuvant Therapy Market Size by Type 8.2.1 Asia-Pacific Adjuvant Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Adjuvant Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Adjuvant Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific Adjuvant Therapy Market Size by Application 8.3.1 Asia-Pacific Adjuvant Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Adjuvant Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Adjuvant Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific Adjuvant Therapy Market Size by Region 8.4.1 Asia-Pacific Adjuvant Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Adjuvant Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Adjuvant Therapy Market Size (2017-2028) 9.2 Latin America Adjuvant Therapy Market Size by Type 9.2.1 Latin America Adjuvant Therapy Market Size by Type (2017-2022) 9.2.2 Latin America Adjuvant Therapy Market Size by Type (2023-2028) 9.2.3 Latin America Adjuvant Therapy Market Share by Type (2017-2028) 9.3 Latin America Adjuvant Therapy Market Size by Application 9.3.1 Latin America Adjuvant Therapy Market Size by Application (2017-2022) 9.3.2 Latin America Adjuvant Therapy Market Size by Application (2023-2028) 9.3.3 Latin America Adjuvant Therapy Market Share by Application (2017-2028) 9.4 Latin America Adjuvant Therapy Market Size by Country 9.4.1 Latin America Adjuvant Therapy Market Size by Country (2017-2022) 9.4.2 Latin America Adjuvant Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Adjuvant Therapy Market Size (2017-2028) 10.2 Middle East & Africa Adjuvant Therapy Market Size by Type 10.2.1 Middle East & Africa Adjuvant Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Adjuvant Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Adjuvant Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa Adjuvant Therapy Market Size by Application 10.3.1 Middle East & Africa Adjuvant Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Adjuvant Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Adjuvant Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa Adjuvant Therapy Market Size by Country 10.4.1 Middle East & Africa Adjuvant Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Adjuvant Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Merck 11.1.1 Merck Company Details 11.1.2 Merck Business Overview 11.1.3 Merck Adjuvant Therapy Introduction 11.1.4 Merck Revenue in Adjuvant Therapy Business (2017-2022) 11.1.5 Merck Recent Developments 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Adjuvant Therapy Introduction 11.2.4 Bayer Revenue in Adjuvant Therapy Business (2017-2022) 11.2.5 Bayer Recent Developments 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Details 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Adjuvant Therapy Introduction 11.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2017-2022) 11.3.5 Johnson & Johnson Recent Developments 11.4 AstraZenca 11.4.1 AstraZenca Company Details 11.4.2 AstraZenca Business Overview 11.4.3 AstraZenca Adjuvant Therapy Introduction 11.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2017-2022) 11.4.5 AstraZenca Recent Developments 11.5 Mylan 11.5.1 Mylan Company Details 11.5.2 Mylan Business Overview 11.5.3 Mylan Adjuvant Therapy Introduction 11.5.4 Mylan Revenue in Adjuvant Therapy Business (2017-2022) 11.5.5 Mylan Recent Developments 11.6 AbbVie 11.6.1 AbbVie Company Details 11.6.2 AbbVie Business Overview 11.6.3 AbbVie Adjuvant Therapy Introduction 11.6.4 AbbVie Revenue in Adjuvant Therapy Business (2017-2022) 11.6.5 AbbVie Recent Developments 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Adjuvant Therapy Introduction 11.7.4 Novartis Revenue in Adjuvant Therapy Business (2017-2022) 11.7.5 Novartis Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Chemotherapy Table 3. Key Players of Radiotherapy Table 4. Key Players of Hormonotherapy Table 5. Key Players of Others Table 6. Global Adjuvant Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Adjuvant Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Adjuvant Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Adjuvant Therapy Market Share by Region (2017-2022) Table 10. Global Adjuvant Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Adjuvant Therapy Market Share by Region (2023-2028) Table 12. Adjuvant Therapy Market Trends Table 13. Adjuvant Therapy Market Drivers Table 14. Adjuvant Therapy Market Challenges Table 15. Adjuvant Therapy Market Restraints Table 16. Global Adjuvant Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Adjuvant Therapy Revenue Share by Players (2017-2022) Table 18. Global Top Adjuvant Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2021) Table 19. Ranking of Global Top Adjuvant Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Adjuvant Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Adjuvant Therapy Product Solution and Service Table 23. Date of Enter into Adjuvant Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Adjuvant Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Adjuvant Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Adjuvant Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Adjuvant Therapy Revenue Share by Application (2017-2022) Table 31. Global Adjuvant Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Adjuvant Therapy Revenue Share by Application (2023-2028) Table 33. North America Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Adjuvant Therapy Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Adjuvant Therapy Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Adjuvant Therapy Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Adjuvant Therapy Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Adjuvant Therapy Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Adjuvant Therapy Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Adjuvant Therapy Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Adjuvant Therapy Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Adjuvant Therapy Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Adjuvant Therapy Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Adjuvant Therapy Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Adjuvant Therapy Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Adjuvant Therapy Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Adjuvant Therapy Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Adjuvant Therapy Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Adjuvant Therapy Market Size by Country (2023-2028) & (US$ Million) Table 63. Merck Company Details Table 64. Merck Business Overview Table 65. Merck Adjuvant Therapy Product Table 66. Merck Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 67. Merck Recent Developments Table 68. Bayer Company Details Table 69. Bayer Business Overview Table 70. Bayer Adjuvant Therapy Product Table 71. Bayer Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 72. Bayer Recent Developments Table 73. Johnson & Johnson Company Details Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Adjuvant Therapy Product Table 76. Johnson & Johnson Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 77. Johnson & Johnson Recent Developments Table 78. AstraZenca Company Details Table 79. AstraZenca Business Overview Table 80. AstraZenca Adjuvant Therapy Product Table 81. AstraZenca Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 82. AstraZenca Recent Developments Table 83. Mylan Company Details Table 84. Mylan Business Overview Table 85. Mylan Adjuvant Therapy Product Table 86. Mylan Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 87. Mylan Recent Developments Table 88. AbbVie Company Details Table 89. AbbVie Business Overview Table 90. AbbVie Adjuvant Therapy Product Table 91. AbbVie Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 92. AbbVie Recent Developments Table 93. Novartis Company Details Table 94. Novartis Business Overview Table 95. Novartis Adjuvant Therapy Product Table 96. Novartis Revenue in Adjuvant Therapy Business (2017-2022) & (US$ Million) Table 97. Novartis Recent Developments Table 98. Research Programs/Design for This Report Table 99. Key Data Information from Secondary Sources Table 100. Key Data Information from Primary Sources List of Figures Figure 1. Global Adjuvant Therapy Market Share by Type: 2021 VS 2028 Figure 2. Chemotherapy Features Figure 3. Radiotherapy Features Figure 4. Hormonotherapy Features Figure 5. Others Features Figure 6. Global Adjuvant Therapy Market Share by Application: 2021 VS 2028 Figure 7. Hospital Case Studies Figure 8. Medical Institution Case Studies Figure 9. Others Case Studies Figure 10. Adjuvant Therapy Report Years Considered Figure 11. Global Adjuvant Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Adjuvant Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Adjuvant Therapy Market Share by Region: 2021 VS 2028 Figure 14. Global Adjuvant Therapy Market Share by Players in 2021 Figure 15. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2021 Figure 17. North America Adjuvant Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Adjuvant Therapy Market Size Market Share by Type (2017-2028) Figure 19. North America Adjuvant Therapy Market Size Market Share by Application (2017-2028) Figure 20. North America Adjuvant Therapy Market Size Share by Country (2017-2028) Figure 21. United States Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Adjuvant Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Adjuvant Therapy Market Size Market Share by Type (2017-2028) Figure 25. Europe Adjuvant Therapy Market Size Market Share by Application (2017-2028) Figure 26. Europe Adjuvant Therapy Market Size Share by Country (2017-2028) Figure 27. Germany Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Adjuvant Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Adjuvant Therapy Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Adjuvant Therapy Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Adjuvant Therapy Market Size Share by Region (2017-2028) Figure 37. China Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Adjuvant Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Adjuvant Therapy Market Size Market Share by Type (2017-2028) Figure 45. Latin America Adjuvant Therapy Market Size Market Share by Application (2017-2028) Figure 46. Latin America Adjuvant Therapy Market Size Share by Country (2017-2028) Figure 47. Mexico Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Adjuvant Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Adjuvant Therapy Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Adjuvant Therapy Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Adjuvant Therapy Market Size Share by Country (2017-2028) Figure 53. Turkey Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Adjuvant Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Merck Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 57. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 58. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 59. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 60. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 61. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 62. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed